These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8263786

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
    Xu G, Salen G, Lea M, Tint GS, Nguyen LB, Batta AK, Chen TS, Shefer S.
    Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
    [Abstract] [Full Text] [Related]

  • 28. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
    Honda A, Shefer S, Salen G, Xu G, Batta AK, Tint GS, Honda M, Chen TC, Holick MF.
    Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
    [Abstract] [Full Text] [Related]

  • 29. Inhibitors of sterol synthesis: 3 beta-hydroxy-25,26,26,26,27,27,27- heptafluoro-5 alpha-cholestan-15-one, an analog of a potent hypocholesterolemic agent in which its major metabolism is blocked.
    Swaminathan S, Siddiqui AU, Pinkerton FD, Gerst N, Wilson WK, Schroepfer GJ.
    Biochem Biophys Res Commun; 1994 May 30; 201(1):168-73. PubMed ID: 8198571
    [Abstract] [Full Text] [Related]

  • 30. Inhibitors of cholesterol biosynthesis as potential hypocholesterolemic drugs.
    Viola F, Balliano G, Cattel L.
    Ital J Biochem; 1989 May 30; 38(4):297A-299A. PubMed ID: 2583986
    [No Abstract] [Full Text] [Related]

  • 31. Policosanol inhibits cholesterol biosynthesis and enhances low density lipoprotein processing in cultured human fibroblasts.
    Menendez R, Fernandez SI, Del Rio A, Gonzalez RM, Fraga V, Amor AM, Mas RM.
    Biol Res; 1994 May 30; 27(3-4):199-203. PubMed ID: 8728831
    [Abstract] [Full Text] [Related]

  • 32. Stigmasterol reduces plasma cholesterol levels and inhibits hepatic synthesis and intestinal absorption in the rat.
    Batta AK, Xu G, Honda A, Miyazaki T, Salen G.
    Metabolism; 2006 Mar 30; 55(3):292-9. PubMed ID: 16483871
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry.
    Dzeletovic S, Breuer O, Lund E, Diczfalusy U.
    Anal Biochem; 1995 Feb 10; 225(1):73-80. PubMed ID: 7778789
    [Abstract] [Full Text] [Related]

  • 35. Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase.
    Singh DK, Li L, Porter TD.
    J Pharmacol Exp Ther; 2006 Sep 10; 318(3):1020-6. PubMed ID: 16714400
    [Abstract] [Full Text] [Related]

  • 36. Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.
    Ku EC.
    Biochem Biophys Res Commun; 1996 Aug 05; 225(1):173-9. PubMed ID: 8769113
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of specific inhibition of sterol biosynthesis on the uptake and utilization of low density lipoprotein cholesterol by HepG2 cells.
    Panini SR, Everson GT, Spencer TA.
    J Lipid Res; 1991 Oct 05; 32(10):1657-65. PubMed ID: 1797946
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.